Cue Biopharma (NASDAQ:CUE) Posts Quarterly Earnings Results

Cue Biopharma (NASDAQ:CUE – Get Free Report) posted its earnings results on Wednesday. The company reported ($0.20) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.09, Zacks reports. The business had revenue of $2.66 million for the quarter, compared to analysts’ expectations of $1.12 million. Cue Biopharma had a negative return on […]

Leave a Reply

Your email address will not be published.

Previous post Analysts Set Expectations for Illumina, Inc.’s FY2024 Earnings (NASDAQ:ILMN)
Next post Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE:VLRS) Short Interest Update